Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
1980.9000
26.10
(
1.34
%)
NSE
Jul 04, 2025
15:31 PM
Volume:
935.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
08 Aug 2024
US FDA Approval
1980.90
1.34%
Result Update:Lupin
Buy:
Lupin Ltd.
by
Axis Direct
Target: 2200 | Target met
Target
Axis Direct
We have BUY on the Stock
Lupin Ltd. has an
average target
of 2343.89 from 9 brokers.
More from Lupin Ltd.
Recommended
Five Interesting Stocks Today - July 04, 2025
The Baseline |
04 Jul 2025, 05:12PM
Market closes higher, Bajaj Finance's AUM grows 25% YoY crore in Q1FY26
Trendlyne Marketwatch |
04 Jul 2025, 04:01PM
Lupin expects normalization by September quarter
|
17 Apr 2020